Healthcare & Medical

Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib

HONG KONG: HONG KONG, July 8, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced the closing of its previously announced exclusive licensing and collaboration agreement with Travere Therapeutics, ...

Germany Sets New Six-Month Start-Up Record / More entrepreneurs founded start-ups in Germany in the first half of 2026 than in any comparable period – one main reason is AI

Berlin: The first six months of this year saw the founding of a record 3053 fledgling tech companies. That’s according to a study carried out by the interest group German Startups Association and the databa ...

Grünenthal successfully completes Phase I trial with Nociceptin Receptor (NOP) Agonist

Aachen: - The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. - In a Phase I trial, the in ...

Improving Appetite Regulation: Organic Methods to Boost GLP-1 Production

: Ozempic and Wegovy are the $1,000-a-month prescription medications that increase GLP-1 - the gut hormone that controls appetite and regulates blood sugar. The Best GLP1 Supplements website exists to a ...

Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Heruis budesonide enteric capsules, further enhancing patient access to the medication

HONG KONG: HONG KONG, Jun 24, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that Everest Medicines and Hainan Herui have entered into a commercialization collaboration relating to Hainan Her ...

CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the Worlds First Bispecific Antibody for Passive Immunization Against Rabies

SHENZHEN: SHENZHEN, June 22, 2026 - (ACN Newswire) - China Medical System Holdings Limited (867.HK/8A8.SG) (“CMS”, or the “Group”) is pleased to announce that, the New Drug Application for Silevimig Inj ...

Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity

Tübingen: Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss, today announced positive top-line efficacy results from its comple ...

ERA 2026: HighTide Therapeutics Presents New Findings Supporting HTD1801 Renoprotective Potential in Oral Presentation

Glasgow / Hong Kong: GLASGOW / HONG KONG - Jun 5, 2026 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), an innovative biopharmaceutical company specializing in the development of multifunctional, multi-targeted t ...

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion

HONG KONG: HONG KONG, Jun 4, 2026 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration agreement with Travere Therapeutics, Inc. (NASDAQ ...

Materna opens a site in Brussels

Brussels: More capacity to deliver in European digital projects The Materna Group has established a subsidiary, Materna Belgium B.V., in the Belgian capital. This move reflects a trend that is gaining increas ...